Alvotech (ALVO) News Today $8.01 -0.32 (-3.84%) Closing price 05/6/2025 03:59 PM EasternExtended Trading$8.55 +0.54 (+6.74%) As of 05:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech's Product Revenues in 2025May 7 at 5:00 AM | globenewswire.comPotential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech's Product Revenues in 2025May 7 at 5:00 AM | globenewswire.comFDA approves Selarsdi injection as interchangeable with StelaraMay 6 at 6:18 AM | finance.yahoo.comWhy Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?May 5 at 12:00 PM | benzinga.comAlvotech’s SELARSDI Gains FDA Approval for Interchangeability with StelaraMay 5 at 9:14 AM | tipranks.comFDA Approves Alvotech's SELARSDI as Interchangeable with Stelara | ALVO stock newsMay 5 at 8:08 AM | gurufocus.comTeva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)May 5 at 8:07 AM | financialpost.comTeva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)May 5 at 7:00 AM | globenewswire.comAlvotech (NASDAQ:ALVO) Short Interest UpdateAlvotech (NASDAQ:ALVO - Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 794,500 shares, an increase of 23.7% from the March 31st total of 642,500 shares. Based on an average daily volume of 149,700 shares, the days-to-cover ratio is currently 5.3 days. Currently, 0.7% of the shares of the stock are sold short.May 4 at 2:24 AM | marketbeat.comAlvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDTMay 2, 2025 | globenewswire.comAlvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT (14:00 CET)May 2, 2025 | globenewswire.comShort Interest in Alvotech (NASDAQ:ALVO) Rises By 23.7%May 2, 2025 | americanbankingnews.comAlvotech: Potential Victim Of Pharma Tariff Threats (Rating Downgrade)April 30, 2025 | seekingalpha.comLegal & General Group Plc Lowers Stock Position in Alvotech (NASDAQ:ALVO)Legal & General Group Plc trimmed its position in Alvotech (NASDAQ:ALVO - Free Report) by 42.2% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 576,189 shares of the company's stock after selling 420,869 shares during the period. Legal & GeApril 21, 2025 | marketbeat.comFY2025 EPS Estimates for Alvotech Lowered by Northland CapmkAlvotech (NASDAQ:ALVO - Free Report) - Equities researchers at Northland Capmk cut their FY2025 earnings per share (EPS) estimates for Alvotech in a report issued on Thursday, April 10th. Northland Capmk analyst C. Byrnes now forecasts that the company will post earnings of $0.00 per share for thApril 15, 2025 | marketbeat.comXbrane Biopharma AB: Announcement from extra general meeting in Xbrane Biopharma ABApril 14, 2025 | finanznachrichten.deAlvotech (NASDAQ:ALVO) Hits New 12-Month Low - Here's What HappenedAlvotech (NASDAQ:ALVO) Sets New 12-Month Low - Here's WhyApril 12, 2025 | marketbeat.comAlvotech (NASDAQ:ALVO) Trading Down 6.9% - Here's What HappenedAlvotech (NASDAQ:ALVO) Stock Price Down 6.9% - What's Next?April 11, 2025 | marketbeat.comAlvotech (NASDAQ:ALVO) Stock Price Down 3.5% - Here's WhyAlvotech (NASDAQ:ALVO) Shares Down 3.5% - Here's WhyApril 4, 2025 | marketbeat.comAlvotech (NASDAQ:ALVO) Hits New 1-Year Low - Here's WhyAlvotech (NASDAQ:ALVO) Sets New 52-Week Low - What's Next?April 4, 2025 | marketbeat.comAlvotech (NASDAQ:ALVO) Shares Sold by Oaktree Capital Management LPOaktree Capital Management LP cut its holdings in Alvotech (NASDAQ:ALVO - Free Report) by 23.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,925,705 shares of the company's stock after selling 606,322 sharesMarch 31, 2025 | marketbeat.comAlvotech (NASDAQ:ALVO) Just Reported And Analysts Have Been Lifting Their Price TargetsMarch 30, 2025 | finance.yahoo.comAlvotech (ALVO) Gets a Buy from Northland SecuritiesMarch 28, 2025 | markets.businessinsider.comAlvotech appoints Balaji Prasad as chief strategy officerMarch 28, 2025 | markets.businessinsider.comAlvotech Full Year 2024 Earnings: Revenues Beat Expectations, EPS LagsMarch 28, 2025 | finance.yahoo.comThis Is a Test From GlobeNewswireMarch 28, 2025 | globenewswire.comAlvotech (NASDAQ:ALVO) Shares Down 7.6% - Here's What HappenedAlvotech (NASDAQ:ALVO) Shares Down 7.6% - Should You Sell?March 28, 2025 | marketbeat.comAlvotech Achieves Record Revenue Growth in 2024March 28, 2025 | tipranks.comAlvotech (NASDAQ:ALVO) Announces Earnings ResultsAlvotech (NASDAQ:ALVO - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.24) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.74) by $0.50.March 27, 2025 | marketbeat.comAlvotech 2024 Q4 - Results - Earnings Call PresentationMarch 27, 2025 | seekingalpha.comAlvotech Achieves Record 2024 Financial Results and Expands Biosimilar PipelineMarch 27, 2025 | tipranks.comAlvotech Appoints Dr. Balaji V. Prasad as Chief Strategy OfficerMarch 27, 2025 | globenewswire.comAlvotech Appoints Dr. Balaji V. Prasad as Chief Strategy OfficerMarch 27, 2025 | globenewswire.comAlvotech Reports Record Results for 2024 and Provides Business UpdateMarch 26, 2025 | globenewswire.comAlvotech Reports Record Results for 2024 and Provides Business UpdateMarch 26, 2025 | globenewswire.comAlvotech’s Biosimilar to Xolair Gains UK Regulatory AcceptanceMarch 26, 2025 | tipranks.comAlvotech's AVT23 Biosimilar Receives UK MHRA Marketing Application AcceptanceMarch 26, 2025 | gurufocus.comUK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)March 26, 2025 | globenewswire.comUK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)March 26, 2025 | globenewswire.comRoyce & Associates LP Buys 28,000 Shares of Alvotech (NASDAQ:ALVO)Royce & Associates LP boosted its stake in Alvotech (NASDAQ:ALVO - Free Report) by 21.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 159,000 shares of the company's stock after buyingMarch 22, 2025 | marketbeat.comAlvotech Strengthens Biosimilar Portfolio With $27 Million Xbrane R&D DealMarch 20, 2025 | benzinga.comAlvotech acquires Xbrane’s R&D operations in Sweden and biosimilar candidate XB003March 20, 2025 | seekingalpha.comAlvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and ProductionMarch 20, 2025 | markets.businessinsider.comAlvotech acquires Xbrane’s R&D operations in Sweden and biosimilar candidate XB003March 20, 2025 | msn.comAlvotech Acquires Xbrane's R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and ProductionMarch 20, 2025 | globenewswire.comAlvotech Acquires Xbrane's R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and ProductionMarch 20, 2025 | globenewswire.comAlvotech (ALVO) Expected to Announce Quarterly Earnings on WednesdayAlvotech (NASDAQ:ALVO) will be releasing earnings after the market closes on Wednesday, March 26, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=669439)March 19, 2025 | marketbeat.comDr. Reddy’s, Alvotech announce FDA acceptance of BLA for AVT03March 18, 2025 | msn.comAlvotech and Dr. Reddy’s gets FDA nod for Biologic License Application for AVT03March 18, 2025 | msn.comFDA Accepts Alvotech’s BLA for Biosimilar AVT03March 18, 2025 | tipranks.com Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter. Email Address ALVO Media Mentions By Week ALVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALVO News Sentiment▼0.560.69▲Average Medical News Sentiment ALVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALVO Articles This Week▼123▲ALVO Articles Average Week Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies QGEN News Today ROIV News Today RVMD News Today LNTH News Today BBIO News Today TGTX News Today LEGN News Today SRPT News Today TLX News Today ADMA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALVO) was last updated on 5/7/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alvotech Please log in to your account or sign up in order to add this asset to your watchlist. Share Alvotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALVO Stock Free ALVO Stock Alerts